Cambridge, Massachusetts-based Common Sensing, which specializes in connected containers for injectable medications, has raised $6.6 million in Series A funding. The round was led by Waterline Ventures, with New World Health, Royal Philips, and Haselmeier also participating.
The funding will be used to accelerate manufacturing and commercial operations for Common Sensing’s GoCap, a dose and...
Health2047, the American Medical Association-backed technology innovation enterprise, is working with pharma company Celgene to create a new healthcare information transfer system. As part of the deal, Health2047 is developing a new data transfer protocol for healthcare, focused on security, trustworthiness, and connectivity. More.
...
Samsung recently announced two interesting partnerships...
Sanofi and Innovation Health — an insurance company jointly run by Inova and Aetna —have announced a pilot program examining the impact of digital health strategies to improve care for Type 2 diabetes patients.
The program will tap One Drop, a diabetes self-management app and Bluetooth blood sugar monitor, and Gocap, a mobile-friendly device and insulin dose management platform that emphasizes...
Common Sensing, a Cambridge-based company developing a smart connected insulin pen cap, announced that it will test its device in a clinical trial in collaboration with Joslin Diabetes Center, Sanofi, and Dexcom.
The study of 125 subjects will be conducted by Joslin and funded by Sanofi. Patients will be given a Gocap from Common Sensing, a cap that fits on to a disposable insulin pen and can...
